Wallingford, CT, United States of America

Walter J Krol

This inventor holds 3 USPTO granted patents. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1995-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Wallingford, CT (US) (1995 - 1996)
  • Newtown, PA (US) (1996)

Company Filing History:


Years Active: 1995-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Walter J Krol: Innovator in Cancer Research

Introduction

Walter J Krol is a notable inventor based in Wallingford, CT (US). He has made significant contributions to the field of cancer research, particularly through his work on the synthesis of taxol, a vital compound in cancer treatment. With a total of 3 patents to his name, Krol's innovations have the potential to impact the medical community profoundly.

Latest Patents

Krol's latest patents focus on the total synthesis of taxol. The first patent provides two basic routes for the total synthesis of taxol, along with the intermediates produced in these processes. These intermediates and analogs to taxol may prove to be valuable anticancer agents. The second patent expands on this work by offering three basic routes for the total synthesis of taxol and its analogues, including nortaxol. This research is crucial for developing new treatments for cancer.

Career Highlights

Walter J Krol is affiliated with the Sloan-Kettering Institute for Cancer Research, where he has dedicated his career to advancing cancer treatment through innovative research. His work has garnered attention in the scientific community, highlighting the importance of synthetic chemistry in developing effective cancer therapies.

Collaborations

Krol has collaborated with esteemed colleagues such as Samuel J Danishefsky and William G Bornmann. These partnerships have further enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Walter J Krol's contributions to cancer research through his innovative patents on taxol synthesis demonstrate his commitment to improving cancer therapies. His work continues to inspire future research in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…